However, we found that CIP2A inhibition by shRNA and small compounds inhibited OXPHOS and prompted NSCLC cells to undergo glycolysis through dephosphorylation of PKM2 pS287, indicating that cancer cells might undergo metabolic reprograming in response to therapeutic stress. Here, CIP2A is linked to cancer.